BSEIndia
      Close  
NOTICES
Notice No.   20231013-33   Notice Date   13 Oct 2023
Category   Trading   Segment   Equity
Subject   Opening of Offer to Buy – Acquisition Window (Takeover) of SUVEN PHARMACEUTICALS LIMITED.
Attachments   Letter of Offer.pdf ;
Content

Trading Members and Custodians are requested to note that Securities Exchange Board of India (SEBI) has issued Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeover, Buy Back and De-listing vide its circular no. CIR/CFD/POLICYCELL/1/2015 dated April 13, 2015 and no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016. The Exchange vide its notice no. 20170210-16 dated Feb 10, 2017,20190424-35 dated April 24, 2019 and 20200528-32 dated 28 May 2020, 20201102-43 dated 02 Nov 2020, 20210825-62 dated Aug 25,2021 has issued Revised Guidelines of Mechanism for acquisition of shares through Stock Exchange pursuant to Tender-Offers under Takeovers, Buy Back and Delisting.

 

All market participants are hereby informed that an open offer is made by Berhyanda Limited (“Acquirer”) (hereinafter referred to as the “Acquirer”) Along with Berhyanda Midco Limited and Jusmiral Midco Limited (Pac 1 and Pac 2 are collectively referred to as “Pacs”) to the public shareholders of SUVEN PHARMACEUTICALS LIMITED (“Target Company”) at a price of Rs. 495/- (Four Hundred &  Ninety Five Only) per equity share (“offer price”), payable in cash, to acquire up to 6,61,86,889 (Six Crore Sixty One Lakh Eighty Six Thousand Eight Hundred Eighty Nine) equity shares of face value of Rs. 1/- each (“offer shares”), representing 26% (Twenty Six Per Cent) of the voting share capital (as defined below) in accordance with the securities and exchange board of India (substantial acquisition of shares and takeovers) regulations, 2011 and subsequent amendments thereto (“SEBI (SAST) regulations”) from the public shareholders pursuant to and in compliance with the provisions of Regulation 3(1), Regulation 4 and other applicable regulations of the SEBI (SAST) Regulations. From Friday, 20 October, 2023 to Friday, 3 November, 2023 (Excluding October 24, 2023 due to Trading Holiday).

 

Letter of Offer is herewith attached for your perusal.

 

Market participants are further requested to note that this offer will be as per the Revised Guidelines of SEBI circular no. CFD/DCR2/CIR/P/2016/131 dated Dec 09, 2016 and Exchange notice no. 20170210-16 dated Feb 10, 2017 and 20190424-35 dated April 24, 2019 along with the details of this Offer to Buy would be available on BSE Website – www.bseindia.com.

 

 

Mangesh Tayde

Deputy General Manager

Listing

October 13, 2023